Related Experiment Video
Updated: Jun 10, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Secondary and primary repolarization changes in left ventricular hypertrophy: a model study
Ljuba Bacharova1, Vavrinec Szathmary, Anton Mateasik
1International Laser Center, Bratislava, Slovakia. bacharova@ilc.sk
Insights
Reduced conduction velocity and prolonged action potential duration both prolong the QT interval in left ventricular hypertrophy (LVH). Distinct ECG patterns differentiate these changes, aiding LVH evaluation.
Area of Science:
- Cardiology
- Computational Biology
- Biophysics
Background:
- Left ventricular hypertrophy (LVH) alters cardiac electrophysiology.
- Understanding the specific contributions of conduction velocity (CV) and action potential duration (APD) to ECG changes in LVH is crucial.
Purpose of the Study:
- To investigate the distinct roles of reduced CV and prolonged APD in QT interval prolongation and T wave/vector loop morphology in simulated LVH.
- To differentiate ECG patterns associated with secondary repolarization abnormalities (CV slowing) versus primary repolarization abnormalities (APD prolongation) in LVH.
Main Methods:
- Utilized an analytical computer model to simulate three types of anatomic LVH: concentric, eccentric, and dilatation.
- Simulated depolarization changes via CV slowing and repolarization changes via APD prolongation.
- Analyzed resultant QT interval, QRS morphology, T wave morphology, and T vector loop characteristics.
Main Results:
- Both CV slowing and APD prolongation prolonged the QT interval in LVH.
- CV slowing (secondary repolarization changes) resulted in pronounced QRS alterations, narrow discordant T loops, and ST strain patterns.
- APD prolongation (primary repolarization changes) showed minimal QRS changes, higher T/QRS ratio, widened T loops, and notched/bifid T waves.
Conclusions:
- LVH induces significant changes in both CV and APD, impacting ECG morphology.
- Simulations highlight distinct ECG signatures for CV slowing versus APD prolongation in LVH.
- Simultaneous analysis of QRS, T wave morphology, and QT interval is essential for accurate clinical LVH evaluation.
Abstract:
The contributions of reduced conduction velocity (CV) and prolonged action potential duration (APD) to QT interval prolongation and T wave and T vector loop morphology in left ventricular hypertrophy (LVH) were studied using an analytical computer model. Three types of anatomic LVH were simulated: concentric and eccentric hypertrophy, and left ventricular dilatation. In each LVH type, depolarization changes were simulated by CV slowing and primary repolarization changes by APD prolongation. Both CV slowing and APD prolongation prolonged the QT interval; however, the secondary and primary repolarization changes differed in additional electrocardiogram (ECG) characteristics creating specific vectorcardiographic/ECG patterns. The secondary repolarization changes were characterized by prolonged QT interval, accompanied by pronounced QRS changes, including increased maximum spatial QRS vector magnitude, prolonged QRS duration, QRS morphology consistent with intraventricular conduction delay, lower values of the T/QRS duration ratio, increased maximum spatial T vector magnitude, narrow and prolonged discordant T vector loops, and discordant tall T waves creating a pattern of ST strain in the precordial ECG leads. QT prolongation in primary repolarization changes was accompanied with inconsiderable changes of QRS amplitude and duration, higher values of the T/QRS duration ratio, widened rounded T loops, and notched or bifid T waves in left precordial leads of the 12-lead ECG. These simulation data are consistent with the accumulated evidence suggesting that LVH induces changes in CV and APD. Our results emphasize the need for simultaneous consideration of morphologic QRS and T wave patterns together with QT prolongation in clinical evaluation of LVH.
Related Concept Videos
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy

